The announcement by Mersana Therapeutics regarding its capital resources is a strong indicator of financial health and operational stability. For investors, this news is likely to be seen as a positive development, as it reduces the risk of dilutive capital raises in the near term and underscores the company's confidence in its current operating plan. This could lead to increased investor confidence and potentially a positive impact on the stock price in the short term.